Skin care represents 11.7% of application sales and powder accounts for 16.2% within the product form segment in 2025. The recombinant collagen market was valued at USD 55.9 million in 2025, is projected to reach USD 176.6 million by 2035 and is forecast to post a 12.2% CAGR between 2025 and 2035.